Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results

Go back to Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
(NASDAQ: LRMR) Delayed: 3.42 +0.32 (10.32%)
Previous Close $3.10    52 Week High
Open $3.17    52 Week Low
Day High $3.44    P/E N/A 
Day Low $3.13    EPS
Volume 1,342,528